戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 yocardial infarction, and had multivessel or left main disease.
2 mplex multivessel coronary artery disease or left main disease.
3 8 patients, 78.5% had 3-vessel and 47.1% had left main disease.
4 y artery bypass graft (CABG) for unprotected left main disease.
5 w symptom burden, and excluded patients with left main disease.
6 erity, heart failure, ejection fraction, and left main disease.
7  from the 4 major PCI versus CABG trials for left main disease.
8 -eluting stents versus CABG in patients with left main disease.
9 cy (>0.9) of ChatGPT-4, including those with left main disease, 3 vessel disease, and diabetic patien
10 tients has been limited mainly to those with left main disease, 3-vessel disease with diabetes, or de
11 0% (adjusted OR=1.16 [95% CI 1.03 to 1.31]), left main disease (adjusted OR=1.15 [95% CI 1.00 to 1.32
12 mes in patients with 3-vessel disease and/or left main disease after percutaneous coronary interventi
13 al impairment, diabetes, and multivessel and left main disease (all p <= 0.0001).
14 n-pump surgery particularly in patients with left main disease and extensive underlying myocardial is
15 evascularization rate, whereas advanced age, left main disease, and smoking were associated with a lo
16 a glomerular filtration rate <30 mL/min, and left main disease, and they presented more often with cl
17 ographically obstructive three-vessel and/or left main disease based on conventional cardiac risk ass
18 ollowing off-pump versus on-pump surgery for left main disease by performing a post hoc analysis from
19                             In patients with left main disease considered equally suitable for PCI or
20                    Over 20% of patients with left main disease currently receive stents, and there is
21 ined stable, and the rate of 3-vessel and/or left main disease declined (-22%, 95% CI -8% to -33%).
22  included fewer diseased vessels, absence of left main disease, fewer bypass grafts, no previous CABG
23 tenosis of the left anterior descending), or left main disease (&gt; or = 50%); "critical" stenosis was
24  beneficial, whereas renal insufficiency and left main disease increase the risk of early and late de
25            Patients with significant (>=50%) left main disease (LMD) have a high risk of cardiovascul
26 ears old) with 3-vessel disease (3VD) and/or left main disease (LMD).
27                             In patients with left main disease or a SYNTAX score </=22, however, DES-
28 gh-risk patients defined by anatomy (such as left main disease) or stress-induced ischemia.
29 ded age (p = 0.0024), prior AF (p = 0.0007), left main disease (p = 0.01), number of vessels bypassed
30 s with serial stenosis, bifurcation lesions, left main disease, saphenous vein graft disease, and acu
31 In patients with three-vessel disease and/or left main disease, selecting revascularization strategy
32 atients with severe, complex multivessel, or left main disease, some patients present with clinical f
33 the current data comparing PCI with CABG for left main disease, summarize recent guideline recommenda
34 =0.02), driven by lower rates of 3-vessel or left main disease than men (STEMI: 38.8% versus 58.7%; S
35 congestive heart disease, renal failure, and left main disease) that were consistent with other repor
36 aphic coronary artery disease was defined as left main disease, three-vessel disease or two-vessel di
37 ften indicated for symptomatic patients with left-main disease, three-vessel disease, or two-vessel d
38 cularization]) that randomized patients with left main disease to PCI or CABG.
39                          Among patients with left main disease treated with CABG in the EXCEL trial,
40 nalysis of all randomized CABG versus PCI in left main disease trials, the gain associated with CABG
41 litaxel-eluting stents (PES) for unprotected left main disease (ULMD).
42             In patients with 3-vessel and/or left main disease undergoing percutaneous coronary inter
43 na, class III-IV heart failure, and 3-vessel/left main disease were excluded.
44 d 20076 adult patients with triple-vessel or left-main disease who underwent primary isolated coronar
45 was to investigate outcomes in patients with left main disease with and without diabetes randomized t
46 lly relevant effect on the FFR assessment of left main disease with the pressure wire in a nonstenose